Top Markets
Coin of the day
Novan, Inc. Novan, Inc.

Novan, Inc.

NOVN
Classement en actions #39523
Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in... Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206, an antiviral gel targeting viral skin infections; SB208, a broad-spectrum antifungal gel designed to combat various fungal skin and nail infections like athlete's foot; and SB414, a cream-based gel formulated for inflammatory skin diseases. Additionally, Novan is advancing SB207 to treat external genital warts, WH602 (an intravaginal gel) and WH504 (a non-gel formulation) both addressing high-risk human papillomavirus (HPV), and SB019, a candidate for SARS-CoV-2. The firm has cultivated strategic partnerships, holding a licensing agreement with Sato Pharmaceutical Co., Ltd., and engaging in a strategic alliance with Orion Corporation. Founded in 2006, Novan, Inc. maintains its headquarters in Durham, North Carolina.
Prix de l'action
$0.056
Dernière synchronisation: 2023-08-21
Capitalisation boursière
$451.38K
Changement (1 jour)
8.74%
Changement (1 an)
0.00%
Pays
US
Échange Novan, Inc. (NOVN)

Catégorie

Historique du prix de l'action pour Novan, Inc. (NOVN)
Prix de clôture le plus élevé : $0.05 le 2023-08-01

Prix de clôture le plus bas : $209.16 le 2016-09-01
Historique du prix de l'action de Novan, Inc. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -95.77%
2022 -71.33%
2021 -31.07%
2020 -74.28%
2019 118.01%
2018 -74.35%
2017 -83.34%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$733.78 7.43%
CH
$1.07K -6.40%
KR
$260.01 14.86%
BE